As STS1 and STS2 can dephosphorylate many RTKs, such as epidermal growth factor receptor, platelet-derived growth factor receptor and so on [19,21,22], and as STS1 is widely expressed, we believe that at least some pharmacological activities of BC may contribute to targeting STS1/STS2. The gene discussed is UBASH3A; the disease is breast cancer.